The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory ...

My ups and downs were much more intense and severe in my early 20s ... how acceptance is the first step to managing major depressive disorder.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Over the last 20 years, we’ve seen major strides in the treatment options for major depressive disorder ... s usually reserved for people who have severe, drug-resistant depression with bipolar ...

Older adults with major depressive disorder (MDD) demonstrate distinct ... online Dec. 30 in JAMA Network Open. People with severe, treatment-resistant depression who received a nerve-stimulating ...

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to ...

(HealthDay News) — Preventive psychological interventions may be effective for adults with subthreshold depressive symptoms, according to a review published online in the December issue of The Lancet ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

It is primarily used for severe or treatment-resistant depression ... the effectiveness of ECT in reducing symptoms of major depressive disorder. For instance, a systematic review highlighted ...

The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...